UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 215

Sortiert nach

Nanobody conjugated PLGA nanoparticles for active targeting of African Trypanosomiasis

Journal of controlled release, 2015-01, Vol.197, p.190-198

2015

Link zum Volltext

Verfügbarkeit prüfen

Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19

Frontiers in immunology, 2022-05, Vol.13, p.891456-891456

2022

Link zum Volltext

Verfügbarkeit prüfen

Brief Report: Response to Hepatitis A Virus Vaccine in HIV-Infected Patients Within a Retrospective, Multicentric Cohort: Facing Hepatitis A Outbreaks in the Clinical Practice

Journal of acquired immune deficiency syndromes (1999), 2019-05, Vol.81 (1), p.e1

2019

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of Fosamprenavir plus Ritonavir in Human Immunodeficiency Virus Type 1-Infected Adult Subjects with Hepatic Impairment

Antimicrobial Agents and Chemotherapy, 2009-12, Vol.53 (12), p.5185-5196

2009

Link zum Volltext

Verfügbarkeit prüfen

Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists

AIDS reviews, 2010-07, Vol.12 (3), p.135-148

2010

Link zum Volltext

Verfügbarkeit prüfen

Analysis of resilience and sexual behavior in persons with HIV infection

Psicologia, reflexão e crítica, 2017-10, Vol.30 (1), p.21-21, Article 21

2017

Link zum Volltext

Verfügbarkeit prüfen

Specific Cell Targeting Therapy Bypasses Drug Resistance Mechanisms in African Trypanosomiasis

PLoS pathogens, 2015-06, Vol.11 (6), p.e1004942

2015

Link zum Volltext

Verfügbarkeit prüfen

Nuke‐sparing regimens as a main simplification strategy and high level of toxicity resolution after antiretroviral switch: the SWITCHART Study

Journal of the International AIDS Society, 2014-11, Vol.17 (4 Suppl 3), p.19819-n/a

2014

Link zum Volltext

Verfügbarkeit prüfen

Ruminococcus gnavus bacteremia: Literature review and a case report associated to acute flare of ulcerative colitis in an immunocompromised patient

Anaerobe, 2023-08, Vol.82, p.102762

2023

Link zum Volltext

Verfügbarkeit prüfen

Monotherapy with darunavir/ritonavir is effective and safe in clinical practice

Journal of the International AIDS Society, 2014-11, Vol.17 (4 Suppl 3), p.19813-n/a

2014

Link zum Volltext

Verfügbarkeit prüfen

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48‐week analysis of the PROTEST study

Journal of the International AIDS Society, 2014-11, Vol.17 (4 Suppl 3), p.19520-n/a

2014

Link zum Volltext

Verfügbarkeit prüfen

Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools

Journal of medical virology, 2009-05, Vol.81 (5), p.763-767

2009

Link zum Volltext

Verfügbarkeit prüfen

Quantification of Viral Loads Lower than 50 Copies per Milliliter by Use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 Test, Version 2.0, Can Predict the Likelihood of Subsequent Virological Rebound to >50 Copies per Milliliter

Journal of Clinical Microbiology, 2013-05, Vol.51 (5), p.1555-1557

2013

Link zum Volltext

Verfügbarkeit prüfen

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study

Internal and emergency medicine, 2021-06, Vol.16 (4), p.843-852

2021

Link zum Volltext

Verfügbarkeit prüfen

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply

Internal and emergency medicine, 2021-06, Vol.16 (4), p.1105-1106

2021

Link zum Volltext

Verfügbarkeit prüfen

Empirical treatment with doxycycline of fever of intermediate duration

European journal of clinical microbiology & infectious diseases, 2021-09, Vol.40 (9), p.2047-2050

2021

Link zum Volltext

Verfügbarkeit prüfen

Use of maraviroc in patients with undetectable viral load: efficacy, tolerance and predictors of viral response in MARAVIROC‐cohort study

Journal of the International AIDS Society, 2014-11, Vol.17 (4 Suppl 3), p.19800-n/a

2014

Link zum Volltext

Verfügbarkeit prüfen

High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use

The Journal of infection, 2022-09, Vol.85 (3), p.322-326

2022

Link zum Volltext

Verfügbarkeit prüfen

Nebulized medication is not associated with nosocomial infections. A pilot study

Revista española de quimioterapia, 2015-06, Vol.28 (3), p.154-156

2015

Link zum Volltext

Verfügbarkeit prüfen

Portal and mesenteric vein thrombosis secondary to cytomegalovirus hepatitis

Medicina clínica, 2010-09, Vol.135 (7), p.338

2010

Link zum Volltext

Verfügbarkeit prüfen

Community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients : Validation of severity criteria

American journal of respiratory and critical care medicine, 2000-12, Vol.162 (6), p.2063-2068

2000

Link zum Volltext

Verfügbarkeit prüfen

Ruminococcus gnavus bacteremia: Literature review and a case report associated with acute flare of ulcerative colitis in an immunocompromised patient

Anaerobe, 2023-08, Vol.82, p.102762-102762, Article 102762

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 215

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(185)
Mit Volltextzugriff
(190)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Nanobody conjugated PLGA nanoparticles for active targeting of African Trypanosomiasis

Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19

Brief Report: Response to Hepatitis A Virus Vaccine in HIV-Infected Patients Within a Retrospective, Multicentric Cohort: Facing Hepatitis A Outbreaks in the Clinical Practice

High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial

Effectiveness of Ritonavir-Boosted Protease Inhibitor Monotherapy in Clinical Practice Even with Previous Virological Failures to Protease Inhibitor-Based Regimens

Hepatic Safety of Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate Fixed-Dose Single-Tablet Regimen in HIV-Infected Patients with Active Hepatitis C Virus Infection: The hEPAtic Study

Pharmacokinetics of Fosamprenavir plus Ritonavir in Human Immunodeficiency Virus Type 1-Infected Adult Subjects with Hepatic Impairment

Genotypic determination of HIV tropism - clinical and methodological recommendations to guide the therapeutic use of CCR5 antagonists

Analysis of resilience and sexual behavior in persons with HIV infection

Specific Cell Targeting Therapy Bypasses Drug Resistance Mechanisms in African Trypanosomiasis

Nuke‐sparing regimens as a main simplification strategy and high level of toxicity resolution after antiretroviral switch: the SWITCHART Study

Ruminococcus gnavus bacteremia: Literature review and a case report associated to acute flare of ulcerative colitis in an immunocompromised patient

Monotherapy with darunavir/ritonavir is effective and safe in clinical practice

Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48‐week analysis of the PROTEST study

Improvement in the determination of HIV-1 tropism using the V3 gene sequence and a combination of bioinformatic tools

Quantification of Viral Loads Lower than 50 Copies per Milliliter by Use of the Cobas AmpliPrep/Cobas TaqMan HIV-1 Test, Version 2.0, Can Predict the Likelihood of Subsequent Virological Rebound to >50 Copies per Milliliter

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply

Empirical treatment with doxycycline of fever of intermediate duration

Use of maraviroc in patients with undetectable viral load: efficacy, tolerance and predictors of viral response in MARAVIROC‐cohort study

High efficacy of glecaprevir/pibrentasvir for HCV-infected individuals with active drug use

Nebulized medication is not associated with nosocomial infections. A pilot study

Portal and mesenteric vein thrombosis secondary to cytomegalovirus hepatitis

Community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients : Validation of severity criteria

Ruminococcus gnavus bacteremia: Literature review and a case report associated with acute flare of ulcerative colitis in an immunocompromised patient

Suchergebnisse filtern